1. |
WHO. Obesity and overweight. Fact sheet N311 Updated. 2015-06. http://www.who.int/mediacentre/factsheets/fs311/en/.
|
2. |
Kulig J, Sierzega M, Kolodziejczyk P, et al. Implications of overweight in gastric cancer: a multicenter study in a Western patient population. Eur J Surg Oncol, 2010, 36(10): 969-976.
|
3. |
Wu XS, Wu WG, Li ML, et al. Impact of being overweight on the surgical outcomes of patients with gastric cancer: a meta-analysis. World J Gastroenterol, 2013, 19(28): 4596-4606.
|
4. |
李博斐. 低体重指数是胃癌患者的不良预后因素——基于 2 029 例中国单中心大样本的研究. 临床与病理杂志, 2015, (z1): 32-33.
|
5. |
Lee HH, Park JM, Song KY, et al. Survival impact of postoperative body mass index in gastric cancer patients undergoing gastrectomy. Eur J Cancer, 2016, 52(1): 129-137.
|
6. |
Li L, Ying XJ, Sun TT, et al. Overview of methodological quality of systematic reviews about gastric cancer risk and protective factors. Asian Pac J Cancer Prev, 2012, 13(5): 2069-2079.
|
7. |
Lee AV, Yee D. Targeting IGF-1R: at a crossroad. Oncology (Williston Park), 2011, 25(6): 535-536, 551.
|
8. |
Leroith D, Scheinman EJ, Bitton-Worms K. The role of insulin and insulin-like growth factors in the increased risk of cancer in diabetes. Rambam Maimonides Med J, 2011, 2(2): e0043.
|
9. |
Lee KN, Choi HS, Yang SY, et al. The role of leptin in gastric cancer: clinicopathologic features and molecular mechanisms. Biochem Biophys Res Commun, 2014, 446(4): 822-829.
|
10. |
Donohoe CL, O’Farrell NJ, Doyle SL, et al. The role of obesity in gastrointestinal cancer: evidence and opinion. Therap Adv Gastroenterol, 2014, 7(1): 38-50.
|
11. |
李海军, 车向明, 张正良, 等. 肥胖对小鼠胃癌生长的影响. 西安交通大学学报(医学版), 2015, 36(4): 528-532, 564.
|
12. |
Devesa SS, Fraumeni JF Jr. The rising incidence of gastric cardia cancer. J Natl Cancer Inst, 1999, 91(9): 747-749.
|
13. |
Fock KM. Review article: the epidemiology and prevention of gastric cancer. Aliment Pharmacol Ther, 2014, 40(3): 250-260.
|
14. |
Carr JS, Zafar SF, Saba N, et al. Risk factors for rising incidence of esophageal and gastric cardia adenocarcinoma. J Gastrointest Cancer, 2013, 44(2): 143-151.
|
15. |
Yang P, Zhou Y, Chen B, et al. Overweight, obesity and gastric cancer risk: results from a meta-analysis of cohort studies. Eur J Cancer, 2009, 45(16): 2867-2873.
|
16. |
Chen Y, Liu L, Wang X, et al. Body mass index and risk of gastric cancer: a meta-analysis of a population with more than ten million from 24 prospective studies. Cancer Epidemiol Biomarkers Prev, 2013, 22(8): 1395-1408.
|
17. |
Nilsson M, Johnsen R, Ye W, et al. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA, 2003, 290(1): 66-72.
|
18. |
Robertson EV, Derakhshan MH, Wirz AA, et al. Central obesity in asymptomatic volunteers is associated with increased intrasphincteric acid reflux and lengthening of the cardiac mucosa. Gastroenterology, 2013, 145(4): 730-739.
|
19. |
Steffen A, Huerta JM, Weiderpass E, et al. General and abdominal obesity and risk of esophageal and gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer, 2015, 137(3): 646-657.
|
20. |
Maeda H, Okabayashi T, Nishimori I, et al. Clinicopathologic features of adenocarcinoma at the gastric cardia: is it different from distal cancer of the stomach? J Am Coll Surg, 2008, 206(2): 306-310.
|
21. |
Noh SH, Park SR, Yang HK, et al. Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial. Lancet Oncol, 2014, 15(12): 1389-1396.
|
22. |
Kim JH, Chin HM, Hwang SS, et al. Impact of intra-abdominal fat on surgical outcome and overall survival of patients with gastric cancer. Int J Surg, 2014, 12(4): 346-352.
|
23. |
Wong J, Rahman S, Saeed N, et al. Effect of body mass index in patients undergoing resection for gastric cancer: a single center US experience. J Gastrointest Surg, 2014, 18(3): 505-511.
|
24. |
Ejaz A, Spolverato G, Kim Y, et al. Impact of body mass index on perioperative outcomes and survival after resection for gastric cancer. J Surg Res, 2015, 195(1): 74-82.
|
25. |
Wang W, Zhang X, Shen C, et al. Laparoscopic versus open total gastrectomy for gastric cancer: an updated meta-analysis. PLoS One, 2014, 9(2): e88753.
|
26. |
Son SY, Jung DH, Lee CM, et al. Laparoscopic gastrectomy versus open gastrectomy for gastric cancer in patients with body mass index of 30 kg/m2 or more. Surg Endosc, 2015, 29(8): 2126-2132.
|
27. |
Sugimoto M, Kinoshita T, Shibasaki H, et al. Short-term outcome of total laparoscopic distal gastrectomy for overweight and obese patients with gastric cancer. Surg Endosc, 2013, 27(11): 4291-4296.
|
28. |
Wang Z, Zhang X, Liang J, et al. Short-term outcomes for laparoscopy-assisted distal gastrectomy for body mass index ≥30 patients with gastric cancer. J Surg Res, 2015, 195(1): 83-88.
|
29. |
Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) hospital infection control practices advisory committee. Am J Infect Control, 1999, 27(2): 97-132.
|
30. |
Hirao M, Tsujinaka T, Imamura H, et al. Overweight is a risk factor for surgical site infection following distal gastrectomy for gastric cancer. Gastric Cancer, 2013, 16(2): 239-244.
|
31. |
Bickenbach KA, Denton B, Gonen M, et al. Impact of obesity on perioperative complications and long-term survival of patients with gastric cancer. Ann Surg Oncol, 2013, 20(3): 780-787.
|
32. |
赵飞, 王玉玮. 肥胖对免疫功能的影响. 国外医学(儿科学分册), 2003, 30(6): 316-318.
|
33. |
Tokunaga M, Hiki N, Fukunaga T, et al. Better 5-year survival rate following curative gastrectomy in overweight patients. Ann Surg Oncol, 2009, 16(12): 3245-3251.
|
34. |
Chen HN, Chen XZ, Zhang WH, et al. The impact of body mass index on the surgical outcomes of patients with gastric cancer: a 10-year, single-institution cohort study. Medicine (Baltimore), 2015, 94(42): e1769.
|
35. |
李彬, 张惠玲. 体质指数对胃癌患者术后预后的影响. 实用医学杂志, 2015, 31(10): 1620-1623.
|
36. |
Lianos GD, Bali CD, Glantzounis GK, et al. BMI and lymph node ratio may predict clinical outcomes of gastric cancer. Future Oncol, 2014, 10(2): 249-255.
|